Drug intelligence / Profile preview

xinluosu

Development stage: Unknown
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Xinluosu is a Traditional Chinese Medicine (TCM) formulation, specifically developed as a tablet by Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine. It is currently being evaluated in clinical trials for its effects on human platelet aggregation and function. The drug's primary mechanism involves the inhibition of platelet activation, which is a critical step in the development of thrombotic cardiovascular events. By modulating platelet function in healthy individuals, Xinluosu aims to serve as a preventive measure against cardiovascular diseases by reducing the risk of abnormal platelet activation and aggregation.

Brand names: Xinluosu
Other names: Xinluosu Tablets

Beyond the preview

Go deeper on xinluosu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xinluosu.

Explore the full profile